ICU Medical ROE 2006-2019 | ICUI

Current and historical return on equity (ROE) values for ICU Medical (ICUI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. ICU Medical ROE for the three months ending June 30, 2019 was 12.41%.
ICU Medical ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $0.05B $1.32B 3.67%
2019-03-31 $0.06B $1.28B 4.34%
2018-12-31 $0.03B $1.26B 2.31%
2018-09-30 $0.09B $1.26B 6.96%
2018-06-30 $0.09B $1.26B 7.13%
2018-03-31 $0.02B $1.23B 1.53%
2017-12-31 $0.07B $1.20B 6.00%
2017-09-30 $0.03B $1.14B 2.85%
2017-06-30 $0.05B $1.12B 5.38%
2017-03-31 $0.10B $1.14B 13.31%
2016-12-31 $0.06B $0.66B 10.16%
2016-09-30 $0.06B $0.65B 9.67%
2016-06-30 $0.06B $0.62B 9.50%
2016-03-31 $0.05B $0.60B 9.29%
2015-12-31 $0.05B $0.58B 8.17%
2015-09-30 $0.05B $0.57B 8.82%
2015-06-30 $0.04B $0.54B 7.20%
2015-03-31 $0.03B $0.52B 5.79%
2014-12-31 $0.03B $0.51B 5.31%
2014-09-30 $0.03B $0.49B 6.68%
2014-06-30 $0.04B $0.49B 7.97%
2014-03-31 $0.04B $0.47B 8.51%
2013-12-31 $0.04B $0.47B 9.32%
2013-09-30 $0.04B $0.43B 9.50%
2013-06-30 $0.04B $0.42B 10.11%
2013-03-31 $0.04B $0.40B 11.06%
2012-12-31 $0.04B $0.39B 11.26%
2012-09-30 $0.05B $0.37B 13.56%
2012-06-30 $0.04B $0.35B 13.33%
2012-03-31 $0.04B $0.34B 13.80%
2011-12-31 $0.04B $0.32B 14.38%
2011-09-30 $0.04B $0.31B 11.91%
2011-06-30 $0.04B $0.31B 12.39%
2011-03-31 $0.03B $0.29B 12.73%
2010-12-31 $0.03B $0.27B 11.72%
2010-09-30 $0.03B $0.26B 10.62%
2010-06-30 $0.02B $0.25B 9.30%
2010-03-31 $0.02B $0.25B 8.34%
2009-12-31 $0.03B $0.27B 9.34%
2009-09-30 $0.03B $0.28B 10.58%
2009-06-30 $0.03B $0.27B 11.74%
2009-03-31 $0.03B $0.26B 11.78%
2008-12-31 $0.03B $0.25B 10.59%
2008-09-30 $0.02B $0.24B 9.72%
2008-06-30 $0.02B $0.23B 8.58%
2008-03-31 $0.02B $0.22B 7.67%
2007-12-31 $0.02B $0.21B 10.74%
2007-09-30 $0.03B $0.22B 11.05%
2007-06-30 $0.03B $0.23B 11.53%
2007-03-31 $0.03B $0.23B 13.17%
2006-12-31 $0.03B $0.23B 11.74%
2006-09-30 $0.02B $0.22B 11.27%
2006-06-30 $0.02B $0.21B 11.87%
2006-03-31 $0.02B $0.20B 11.96%
2005-12-31 $0.02B $0.19B 11.43%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.219B $1.400B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $146.323B 26.71
Medtronic (MDT) Ireland $145.061B 20.36
Stryker (SYK) United States $80.552B 27.85
Boston Scientific (BSX) United States $53.588B 25.99
Baxter (BAX) United States $44.924B 27.24
EssilorLuxottica Societe Anonyme (ESLOY) France $32.865B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.253B 18.08
Coloplast (CLPBY) Denmark $25.488B 40.69
Lonza Group Ag (LZAGY) Switzerland $25.356B 0.00
Terumo (TRUMY) Japan $24.335B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.897B 0.00
ResMed (RMD) United States $18.864B 35.95
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.229B 54.83
Insulet (PODD) United States $9.266B 549.07
Perrigo (PRGO) Ireland $7.333B 13.51
Canopy Growth (CGC) Canada $7.030B 0.00
Hill-Rom Holdings (HRC) United States $6.817B 20.33
Haemonetics (HAE) United States $6.460B 48.76
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.786B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.648B 0.00
NuVasive (NUVA) United States $3.463B 27.61
Neogen (NEOG) United States $3.393B 56.77
Quidel (QDEL) United States $2.561B 25.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.550B 0.00
Agios Pharmaceuticals (AGIO) United States $1.943B 0.00
National Vision Holdings (EYE) United States $1.805B 38.97
Cardiovascular Systems (CSII) United States $1.730B 0.00
Aphria (APHA) $1.197B 0.00
VAREX IMAGING (VREX) United States $1.103B 25.42
AtriCure (ATRC) United States $1.057B 0.00
Phibro Animal Health (PAHC) United States $0.853B 13.88
Eagle Pharmaceuticals (EGRX) United States $0.843B 21.50
Omeros (OMER) United States $0.782B 0.00
NanoString Technologies (NSTG) United States $0.760B 0.00
Lantheus Holdings (LNTH) United States $0.732B 19.25
LeMaitre Vascular (LMAT) United States $0.696B 41.24
PetIQ (PETQ) United States $0.676B 15.98
Cerus (CERS) United States $0.627B 0.00
Surmodics (SRDX) United States $0.605B 114.95
MacroGenics (MGNX) United States $0.538B 0.00
Quanterix (QTRX) United States $0.527B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.21
TG Therapeutics (TGTX) United States $0.518B 0.00
Owens & Minor (OMI) United States $0.450B 13.47
Meridian Bioscience (VIVO) United States $0.428B 13.37
Utah Medical Products (UTMD) United States $0.356B 26.11
Zynex (ZYXI) United States $0.340B 36.14
BioLife Solutions (BLFS) United States $0.332B 102.06
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.326B 0.00
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.229B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Repro-Med Systems (REPR) United States $0.163B 0.00
Rockwell Medical (RMTI) United States $0.158B 0.00
Cytosorbents (CTSO) United States $0.146B 0.00
Female Health (VERU) United States $0.140B 0.00
Fonar (FONR) United States $0.130B 9.14
Liberty Health Sciences (LHSIF) Canada $0.106B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Chimerix (CMRX) United States $0.089B 0.00
United-Guardian (UG) United States $0.085B 20.00
Nephros (NEPH) United States $0.083B 0.00
MTech Acquisition (KERN) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Surface Oncology (SURF) United States $0.037B 0.00
Senestech (SNES) United States $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00